Abstract:A particular class of tyrosine-kinases sharing no structural similarity with eukaryotic tyrosine-kinases has been evidenced in a large array of bacterial species. These bacterial tyrosine-kinases are able to autophosphorylate on a C-terminal tyrosine-rich motif. Their autophosphorylation has been shown to play a crucial role in the biosynthesis or export of capsular polysaccharide. The analysis of the first crystal structure of the staphylococcal tyrosine kinase CapB2 associated with the activating domain of t… Show more
“…Somewhat unexpectedly, and in contradiction to a previous report, 19) mutation of the four C-terminal tyrosines to phenylalanines resulted in no reduction of the phosphotyrosine signal (Fig. 3, lane 3).…”
Section: Expression Of Active S Aureus Tyrosine Kinases In Acontrasting
confidence: 98%
“…The kinase activity of CapB2 was also significantly enhanced when it was fused to the C-terminal domain of CapA protein. [18][19][20] Here, we show that the S. aureus BY-kinase CapB2, and possibly CapB1, can be translated into active tyrosine kinases in a human cell line when they are fused to CapA C-terminal cytoplasmic activation domains. This approach provides an efficient and economical method to measure and analyze BYkinases, and could be useful in future enzyme characterization and inhibitor screening.…”
Section: Introductionmentioning
confidence: 76%
“…Mutation of this region in E. coli Wzc decreased autophosphorylation and polysaccharide production 23) but did not inhibit S. aureus CapB2 kinase activity. 20) We changed the three conserved residues to one aspartic acid and two lysines ( Fig. 5 lane 2, DKK) or to three alanines (lane 3, AAA) but did not notice any notable change in phosphotyrosine levels, suggesting that this motif is not essential for CapB2 kinase activity per se.…”
Section: Expression Of Active S Aureus Tyrosine Kinases In Amentioning
confidence: 90%
“…Previous reports have shown that the activity of the S. aureus BYkinase CapB2 is enhanced when it is fused to the C-terminal cytoplasmic tail of the activator CapA1. [18][19][20] Based on these reports, we constructed CapA1/CT-CapB2 by attaching the Cterminal 29 amino acids of CapA1 to the N-terminus of fulllength CapB2 (Fig. 1A).…”
Section: Expression Of Active S Aureus Tyrosine Kinases In Amentioning
Many bacteria encode tyrosine kinases that are structurally unrelated to their eukaryotic counterparts and are termed BY-kinases. Two BY-kinases, CapB1 and CapB2, have been identified in the Staphylococcus aureus genome. Although CapB1 and CapB2 share more than 70% homology, earlier studies with purified enzymes did not find any evident kinase activity in CapB1, whereas CapB2 was autophosphorylated on a C-terminal tyrosine cluster in the presence of the kinase modulator proteins CapA1 or CapA2. For the convenient analysis of BY-kinases, we attempted to express CapB2 in an active form in a mammalian cell line. To this end, the C-terminal activation domain of CapA1 was attached to the N-terminus of CapB2, and the resulting CapA1/CT-CapB2 chimera was further fused with various tags and transfected into HEK293T cells. Immunoblotting analyses showed that when fluorescent protein tags were attached to the N-terminus, CapA1/CT-CapB2 was both expressed and tyrosine phosphorylated in HEK293T cells. Mutation of the ATPbinding lysine abrogated tyrosine phosphorylation, indicating that tyrosine phosphorylation was catalyzed by the transfected bacterial kinase and not by endogenous cellular enzymes. Unexpectedly, mutation of the C-terminal tyrosine cluster did not abolish autophosphorylation. Further analyses revealed that CapA1/CT-CapB2 phosphorylated not only itself but also the attached fluorescent protein tag. Several domains and residues important for tyrosine kinase activity were identified from the production of various mutants. We also present data that CapB1, which was previously thought to be catalytically inert, may possess intrinsic kinase activity.
“…Somewhat unexpectedly, and in contradiction to a previous report, 19) mutation of the four C-terminal tyrosines to phenylalanines resulted in no reduction of the phosphotyrosine signal (Fig. 3, lane 3).…”
Section: Expression Of Active S Aureus Tyrosine Kinases In Acontrasting
confidence: 98%
“…The kinase activity of CapB2 was also significantly enhanced when it was fused to the C-terminal domain of CapA protein. [18][19][20] Here, we show that the S. aureus BY-kinase CapB2, and possibly CapB1, can be translated into active tyrosine kinases in a human cell line when they are fused to CapA C-terminal cytoplasmic activation domains. This approach provides an efficient and economical method to measure and analyze BYkinases, and could be useful in future enzyme characterization and inhibitor screening.…”
Section: Introductionmentioning
confidence: 76%
“…Mutation of this region in E. coli Wzc decreased autophosphorylation and polysaccharide production 23) but did not inhibit S. aureus CapB2 kinase activity. 20) We changed the three conserved residues to one aspartic acid and two lysines ( Fig. 5 lane 2, DKK) or to three alanines (lane 3, AAA) but did not notice any notable change in phosphotyrosine levels, suggesting that this motif is not essential for CapB2 kinase activity per se.…”
Section: Expression Of Active S Aureus Tyrosine Kinases In Amentioning
confidence: 90%
“…Previous reports have shown that the activity of the S. aureus BYkinase CapB2 is enhanced when it is fused to the C-terminal cytoplasmic tail of the activator CapA1. [18][19][20] Based on these reports, we constructed CapA1/CT-CapB2 by attaching the Cterminal 29 amino acids of CapA1 to the N-terminus of fulllength CapB2 (Fig. 1A).…”
Section: Expression Of Active S Aureus Tyrosine Kinases In Amentioning
Many bacteria encode tyrosine kinases that are structurally unrelated to their eukaryotic counterparts and are termed BY-kinases. Two BY-kinases, CapB1 and CapB2, have been identified in the Staphylococcus aureus genome. Although CapB1 and CapB2 share more than 70% homology, earlier studies with purified enzymes did not find any evident kinase activity in CapB1, whereas CapB2 was autophosphorylated on a C-terminal tyrosine cluster in the presence of the kinase modulator proteins CapA1 or CapA2. For the convenient analysis of BY-kinases, we attempted to express CapB2 in an active form in a mammalian cell line. To this end, the C-terminal activation domain of CapA1 was attached to the N-terminus of CapB2, and the resulting CapA1/CT-CapB2 chimera was further fused with various tags and transfected into HEK293T cells. Immunoblotting analyses showed that when fluorescent protein tags were attached to the N-terminus, CapA1/CT-CapB2 was both expressed and tyrosine phosphorylated in HEK293T cells. Mutation of the ATPbinding lysine abrogated tyrosine phosphorylation, indicating that tyrosine phosphorylation was catalyzed by the transfected bacterial kinase and not by endogenous cellular enzymes. Unexpectedly, mutation of the C-terminal tyrosine cluster did not abolish autophosphorylation. Further analyses revealed that CapA1/CT-CapB2 phosphorylated not only itself but also the attached fluorescent protein tag. Several domains and residues important for tyrosine kinase activity were identified from the production of various mutants. We also present data that CapB1, which was previously thought to be catalytically inert, may possess intrinsic kinase activity.
“…However, CapB2 showed significant activity, particularly in the presence of CapA1 (92), which is transcribed at a distant site on the chromosome. There has been a recent suggestion that CapB1 may in fact be a pseudokinase; a protein that while containing a kinase-like domain is actually catalytically inactive (34), and may perform other auxillary roles as has been seen for the pseudokinase, MviN of Mycobacterium tuberculosis (27). The role of these genes within the bacterial cell is yet to be investigated.…”
Section: Regulation Of Capsule Synthesiscontribution Of By-kinase Andmentioning
Significance: Tyrosine phosphorylation and associated protein tyrosine phosphatases are gaining prominence as critical mechanisms in the regulation of fundamental processes in a wide variety of bacteria. In particular, these phosphatases have been associated with the control of the biosynthesis of capsular polysaccharides and extracellular polysaccharides, critically important virulence factors for bacteria. Recent Advances: Deletion and overexpression of the phosphatases result in altered polysaccharide biosynthesis in a range of bacteria. The recent structures of associated auto-phosphorylating tyrosine kinases have suggested that the phosphatases may be critical for the cycling of the kinases between monomers and higher order oligomers. Critical Issues: Additional substrates of the phosphatases apart from cognate kinases are currently being identified. These are likely to be critical to our understanding of the mechanism by which polysaccharide biosynthesis is regulated. Future Directions: Ultimately, these protein tyrosine phosphatases are an attractive target for the development of novel antimicrobials. This is particularly the case for the polymerase and histidinol phosphatase family, which is predominantly found in bacteria. Furthermore, the determination of bacterial tyrosine phosphoproteomes will likely help to uncover the fundamental roles, mechanism, and critical importance of these phosphatases in a wide range of bacteria. Antioxid. Redox Signal. 20, 2274Signal. 20, -2289
The major surface polysaccharides of Staphylococcus aureus include the capsular polysaccharide (CP), cell wall teichoic acid (WTA), and polysaccharide intercellular adhesin/poly-β(1-6)-N-acetylglucosamine (PIA/PNAG). These glycopolymers are important components of the staphylococcal cell envelope, but none of them is essential to S. aureus viability and growth in vitro. The overall biosynthetic pathways of CP, WTA, and PIA/PNAG have been elucidated, and the functions of most of the biosynthetic enzymes have been demonstrated. Because S. aureus CP and WTA (but not PIA/PNAG) utilize a common cell membrane lipid carrier (undecaprenyl-phosphate) that is shared by the peptidoglycan biosynthesis pathway, there is evidence that these processes are highly integrated and temporally regulated. Regulatory elements that control glycopolymer biosynthesis have been described, but the cross talk that orchestrates the biosynthetic pathways of these three polysaccharides remains largely elusive. CP, WTA, and PIA/PNAG each play distinct roles in S. aureus colonization and the pathogenesis of staphylococcal infection. However, they each promote bacterial evasion of the host immune defences, and WTA is being explored as a target for antimicrobial therapeutics. All the three glycopolymers are viable targets for immunotherapy, and each (conjugated to a carrier protein) is under evaluation for inclusion in a multivalent S. aureus vaccine. Future research findings that increase our understanding of these surface polysaccharides, how the bacterial cell regulates their expression, and their biological functions will likely reveal new approaches to controlling this important bacterial pathogen.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.